FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 69 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,253,318 | -34.3% | 202,148 | 0.0% | 0.01% | -41.7% |
| Q1 2024 | $1,908,277 | +39.9% | 202,148 | 0.0% | 0.01% | +33.3% |
| Q4 2023 | $1,364,499 | +52.0% | 202,148 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $897,537 | +34.5% | 202,148 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $667,088 | +53.8% | 202,148 | +32.9% | 0.01% | +25.0% |
| Q1 2023 | $433,622 | -91.8% | 152,148 | -66.4% | 0.00% | -94.7% |
| Q4 2020 | $5,302,000 | +220.4% | 452,797 | +116.9% | 0.08% | +200.0% |
| Q3 2020 | $1,655,000 | +31.7% | 208,757 | +176.3% | 0.02% | +47.1% |
| Q4 2019 | $1,257,000 | +26.0% | 75,551 | -49.7% | 0.02% | +21.4% |
| Q3 2019 | $998,000 | – | 150,265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $70,091,000 | 17.54% |
| TRV GP IV, LLC | 2,343,154 | $41,450,000 | 11.92% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $3,538,000 | 1.49% |
| HighVista Strategies LLC | 89,963 | $1,591,000 | 1.27% |
| Logos Global Management LP | 685,000 | $12,118,000 | 1.25% |
| Monashee Investment Management LLC | 273,045 | $4,830,000 | 1.19% |
| RTW INVESTMENTS, LP | 3,866,872 | $68,405,000 | 1.00% |
| Parkman Healthcare Partners LLC | 250,106 | $4,424,000 | 0.98% |
| Deep Track Capital, LP | 750,000 | $13,268,000 | 0.94% |
| Darwin Global Management, Ltd. | 317,428 | $5,615,000 | 0.86% |